Details for New Drug Application (NDA): 091673
✉ Email this page to a colleague
The generic ingredient in ATAZANAVIR SULFATE is atazanavir sulfate. There are twenty-five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the atazanavir sulfate profile page.
Summary for 091673
Tradename: | ATAZANAVIR SULFATE |
Applicant: | Teva Pharms Usa |
Ingredient: | atazanavir sulfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 091673
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 091673 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-5526 | 0093-5526-06 | 60 CAPSULE in 1 BOTTLE (0093-5526-06) |
ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 091673 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-5527 | 0093-5527-06 | 60 CAPSULE in 1 BOTTLE (0093-5527-06) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Apr 22, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Apr 22, 2014 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 200MG BASE | ||||
Approval Date: | Apr 22, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription